[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.

Item

http://www.wikidata.org/entity/Q39774300

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.

@en

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.

@nl

type

Item

label

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.

@en

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.

@nl

prefLabel

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.

@en

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.

@nl

P1476

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.

@en

P2093

Abraham Fisher

http://www.w3.org/2001/XMLSchema#string

Dirk L Knol

http://www.w3.org/2001/XMLSchema#string

Hans Jc Buiter

http://www.w3.org/2001/XMLSchema#string

Josée E Leysen

http://www.w3.org/2001/XMLSchema#string

Maqsood Yaqub

http://www.w3.org/2001/XMLSchema#string

Marc C Huisman

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET.

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.

A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum

AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.

Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists.

Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain.

PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man.

G protein-coupled receptor allosterism and complexing.

Importance and prospects for design of selective muscarinic agonists.

P2888

2191-219x-3-19

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2191-219X-3-19

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Albert D. Windhorst

Adriaan A Lammertsma

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001260312

http://www.w3.org/2001/XMLSchema#string

P698

23514539

http://www.w3.org/2001/XMLSchema#string

P932

3623648

http://www.w3.org/2001/XMLSchema#string